Skip to main content
OpenTrials

Clinical trial condition

Metastatic Prostate Adenocarcinoma

Explore clinical trials studying Metastatic Prostate Adenocarcinoma. Study availability and eligibility vary by location and protocol.

25 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Prostate Adenocarcinoma trial results

Recruiting

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

NCT06931340

Conditions
Castration-Sensitive Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Kaiser Permanente Dublin Dublin, California, United States
  • Kaiser Permanente-Fremont Fremont, California, United States
View all 195 locations
View Trial Details
Recruiting

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

NCT07200830

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • AIS Cancer Center at San Joaquin Community Hospital Bakersfield, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
View all 102 locations
View Trial Details

Related conditions